Cynical managements have reverse splits so they can give the appearance of a scarcity of shares, a low shares outstanding figure. Then they ramp in special options or payment by shares or share offerings, all highly dilutive actions to the previous common shareholders...that's you. This management is a special case of greed gone wild. The salaries these guys are taking out of ECTE's coffers are shockingly greedy when you consider the backwards progress of ECTE. Something is very wrong and sick here. Stop the reverse split. Roll back the overly greedy compensation of people who work or are connected to ECTE, and then get focused on getting the European and USA trials on schedule and primed for a positive consideration by these regulatory bodies. If there is good news, I'm not adverse to having management paid handsomely for success. But I'm not going to endorse management raiding ECTE's scarce coffers before any good news has arrived, decimating common shareholders in the process.
A reverse split makes no difference whatsoever in the actual value of a company. It can help stop shorting manipulation, and pharms waiting for approvals OFTEN have to do RS to stay on the mainstream exchanges.
This is a completely irresponsible post, knowingly so I am certain. Why don't you do some actual research on stock performance following a r/s and report your findings accurately. They are typically disasterous and desperate maneuvers; end of discussion.